Tag: VRBPAC

FDA Panel Votes to Waive Clinical Trials for New COVID Boosters

Megan Redshaw The U.S. Food and Drug Administration’s (FDA) vaccine advisory panel on Tuesday voted 19 to 2 to recommend new COVID-19 booster shots that include the Omicron variant this fall. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) did not issue guidance on whether additional data would be needed to recommend an updated composition of the primary-series vaccines authorized for […]

Why Big Pharma is Desperate to Get COVID Jab Into Babies

Joseph Mercola The rate of COVID-19 associated hospitalization among children aged 5 to 11 is just 0.0008%. In real-world terms, that’s so close to zero you basically cannot lower it any further. Despite that, the U.S. Food and Drug Administration’s vaccine advisory panel — the Vaccines and Related Biological Products Advisory Committee (VRBPAC) — on […]

FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting

June 28, 2022 At a previous Vaccines and Related Biological Products Advisory (VRBPAC) meeting on April 6, 2022, the committee discussed considerations that should inform strain composition decisions to ensure that available COVID-19 vaccines continue to meet public health needs, when and how frequently to consider strain composition changes, and the process that should be […]

Will FDA Allow Pfizer, Moderna to Skip Clinical Trials for Future COVID Vaccines?

Toby Rogers Pfizer and Moderna have a problem — their COVID-19 shots do NOT work. Everyone knows this. The shots do not stop infection, transmission, hospitalization, or death. … So Pfizer and Moderna have figured out a way to use regulatory capture to get their reformulated COVID-19 shots approved WITHOUT further clinical trials. Their scheme […]